Haematologica (Jul 2021)
IL4-STAT6 signaling induces CD20 in chronic lymphocytic leukemia and this axis is repressed by PI3Kδ inhibitor idelalisib
- Veronika Sandova,
- Gabriela Mladonicka Pavlasova,
- Vaclav Seda,
- Katerina Amruz Cerna,
- Sonali Sharma,
- Veronika Palusova,
- Yvona Brychtova,
- Sarka Pospisilova,
- Stacey M. Fernandes,
- Anna Panovska,
- Michael Doubek,
- Matthew S. Davids,
- Jennifer R. Brown,
- Jiri Mayer,
- Marek Mraz
Affiliations
- Veronika Sandova
- Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Gabriela Mladonicka Pavlasova
- Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- Vaclav Seda
- Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Katerina Amruz Cerna
- Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- Sonali Sharma
- Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- Veronika Palusova
- Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- Yvona Brychtova
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Sarka Pospisilova
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Stacey M. Fernandes
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- Anna Panovska
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Michael Doubek
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Matthew S. Davids
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- Jennifer R. Brown
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- Jiri Mayer
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- Marek Mraz
- Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- DOI
- https://doi.org/10.3324/haematol.2021.278644
- Journal volume & issue
-
Vol. 106,
no. 11
Abstract
No abstracts available.